C9066 is a valid 2023 HCPCS Code that could be used to indicate Injection, sacituzumab govitecan-hziy, 2.5 mg for reimbursement purposes.
C9066 belongs to Other Medical Items or Services Type of Service and has been in effect since Jan 01, 2021.
Sacituzumab govitecan-hziy
C9066 code information
| HCPCS code: | C9066 |
| Description: | INJECTION, SACITUZUMAB GOVITECAN-HZIY, 2.5 MG |
| Effective Date: | Jan 01, 2021 |
| Added Date: | Oct 01, 2020 |
| Termination Date: | HCPCS C9066 was terminated on Dec 31, 2020 |
| Pricing indicator: | 53 - STATUTE |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1D - CHEMOTHERAPY |
| Action code: | D - DISCONTINUE PROCEDURE OR MODIFIER CODE |
| Type of Service: |
9 - OTHER MEDICAL ITEMS OR SERVICES
F - AMBULATORY SURGICAL CENTER (FACILITY USAGE FOR SURGICAL SERVICES)
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to C9066